Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
URGN's RSI(14) currently reads 47. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. As with any single metric, weigh this alongside URGN's full indicator set. → Learn more
ADX currently reads 21. ADX tells you how convincing a trend is, leaving the up-or-down call to +DI/-DI (25+ is considered pronounced). Right now URGN shows +DI and -DI show no clear edge either way, putting it in the 'weak trend' range on ADX. Cross-check this against URGN's other indicators above before drawing a conclusion. → Learn more
URGN's Bollinger Band width is in the bottom 16% (narrow) of its past year, and the squeeze indicator is currently active. This measures how tight the recent trading range is relative to where it normally sits. A squeeze is often followed by a volatility expansion in either direction. Cross-check this against URGN's other indicators above before drawing a conclusion. → Learn more
URGN's OBV is currently rising (1.4x), and the up/down volume ratio is 1.4x. OBV adds volume on up days and subtracts it on down days, building a running estimate of money flow. Treat this as one data point on URGN, not a standalone signal. → Learn more
URGN's recent volume is running at 0.8x its usual level. The volume ratio compares recent trading volume to the stock's usual average volume — a reference point for whether order flow is concentrating around this stock. As with any single metric, weigh this alongside URGN's full indicator set. → Learn more
URGN's change over the last 5 trading days is +1.7%, and over the last 1 trading day is -0.6%. Both figures describe short-term price movement only and are not, on their own, a trading signal.
URGN's current price is 13.8% below its 20-day high. It shows how much room remains between the current price and its own 20-day high-water mark. On this measure it currently falls in the 'distance from high' category. As with any single metric, weigh this alongside URGN's full indicator set. → Learn more
URGN's ATR% currently reads 4.7%, a 'daily range' level. This is a running measure of how much the price typically moves in a single session. This reading is specific to URGN on this scan date and can change quickly. → Learn more
URGN's 20-trading-day relative strength versus SPY (S&P 500 ETF) is -4.6%. URGN gained less (or lost more) than SPY over this stretch. As with any single metric, weigh this alongside URGN's full indicator set. → Learn more
No significant edge was measured for Bollinger Band Squeeze: 28.3% versus a 29.3% base rate across 3949 cases. This reading is specific to URGN on this scan date and can change quickly. → Bollinger Band Squeeze
Measured (n=6001), the hit-rate for OBV Accumulation (26.5%) was not statistically distinguishable from the base rate (29.3%). As with any single metric, weigh this alongside URGN's full indicator set. → OBV Accumulation
Stocks holding Weekly Squeeze reached +15% 25.4% of the time, versus a 29.3% base rate — not a statistically significant difference (5281 cases). This reading is specific to URGN on this scan date and can change quickly. → Weekly Squeeze
Measured (n=1385), the hit-rate for Stage 2 Trend Template (21.4%) was not statistically distinguishable from the base rate (29.3%). This reading is specific to URGN on this scan date and can change quickly. → Stage 2 Trend Template
Avg Daily Range 4%+ has a real, measured edge here: 59.5% hit-rate versus a 29.3% base rate, from 2502 observed cases. Treat this as one data point on URGN, not a standalone signal. → Avg Daily Range 4%+
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (URGN diagnostic as of 2026.09.09 13:06).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.